Chemical Structure (Genvoya 01)
Genvoya Tablet
Product Images NDC 61958-1901
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Genvoya (NDC 61958-1901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Genvoya 02)
Chemical Structure (Genvoya 03)
Chemical Structure (Genvoya 04)
Principal Display Panel (30 Tablet Bottle Label)
Genvoya is a drug produced by Gilead Sciences that contains elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide. It is available in tablet form with each tablet containing 150 mg of elvitegravir, 150 mg of cobicistat, 200 mg of emtricitabine, and 10 mg of tenofovir alafenamide. This drug should be stored below 30°C and should be kept in its original container. The package insert should be consulted for dosage information. The product should be kept away from the reach of children, and the pharmacy label should not cover the alert box. Gilead Sciences is the manufacturer of this product, and it is made in Canada.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
